J Biol Chem, Vol. 274, Issue 3, 1842-1847, January 15, 1999
Isolated Operator Binding and Ligand Response Domains of the TyrR
Protein of Haemophilus influenzae Associate to Reconstitute
Functional Repressor
Shimin
Zhao and
Ronald L.
Somerville
From the Department of Biochemistry, Purdue University, West
Lafayette, Indiana 47907-1153
Highly purified preparations of the TyrR protein
of Haemophilus influenzae Rd undergo specific and limited
proteolytic cleavage during storage at 4 °C to generate two
fragments of 28 and 8 kDa. Under nondenaturing conditions, the two
fragments remain tightly associated. Nicked TyrR is identical to
full-length TyrR in its operator binding characteristics. The 8-kDa
fragment containing amino acid residues 258-318 was separated from the
28-kDa fragment (residues 1-257) by gel filtration chromatography in
the presence of 4 M urea. Upon renaturation, this fragment
bound to operator with an affinity similar to that of full-length TyrR
but was unresponsive to ligands that normally modulate operator binding
(
-S-ATP and L-tyrosine). It was not possible to renature
the urea-treated 28-kDa fragment. Highly purified soluble preparations
of truncated TyrR containing residues 1-257 were obtained after the
overexpression of a shortened form of the tyrR gene via a
specific plasmid construct. By several criteria, this species had
native secondary and tertiary structure. The 28-kDa fragment was unable
to bind to operator but could reconstitute nicked TyrR when added to
the renatured 8-kDa fragment, as shown by physical properties and
responsiveness to cofactors in operator binding. When either the 28- or
8-kDa species was expressed in vivo, there was no
detectable operator binding, as evaluated using a lacZ
reporter system driven by the repressible aroF
promoter. When the two fragments were co-expressed in a common
cytoplasm, an operator-binding species was formed, as demonstrated
through partial restoration of repression capability.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.